Incorporated in 1989, Vaishali Pharma Ltd. is engaged in the manufacturing, trading & marketing of Active Pharmaceutical Ingredients(APIs), pharmaceuticals formulations, surgical products, veterinary supplements, herbal, nutraceutical, and oncology products.
Financial Results:
Vaishali Pharma Ltd reported Revenues for Q1FY24 of ₹13.42 Crores up from ₹10.18 Crore year on year, a rise of 31.83%.
Total Expenses for Q1FY24 of ₹11.66 Crores up from ₹8.60 Crores year on year, a rise of 35.58%.
Consolidated Net Profit of ₹1.59 Crores up 5.3% from ₹1.51 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.50, up 4.90% from ₹1.43 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.